Mobile Hero Image

HIV, Immunology and Infectious Disease

Our Department provides care to people with health problems related to HIV, Viral Hepatitis disorders of the immune system including Allergy, and Infectious Diseases. The Unit’s outpatient service is referred to as Immunology B Ambulatory Care (IBAC).

HIV

Professor Andrew Carr (Director)
Professor Bruce Brew (HIV-Neurology)
Professor David Cooper
Professor Anthony Kelleher

Associate Professor Debbie Marriot
Associate Professor Gail Matthews

Dr Samuel Milliken (HIV-Haematology)
John McAllister (Clinical Nurse Consultant)
 

St Vincent’s has a high number of people living with HIV or at high risk of HIV infection living in its vicinity, and is the largest HIV service in Australia. IBAC is ideally suited to offering treatment for both populations. St Vincent’s Hospital has a long, well-known history as a centre of excellence in the diagnosis and compassionate care of those with HIV. Our services include Specialist Clinics, Nursing Care, Day Treatment and access to Social Work support and Dietician Services. We also provide HIV prevention services including HIV pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), which are both highly effective at preventing HIV infection in those at high risk.

Clinical Trial - HIV & the Brain.

St Vincent's is currently looking for people living with HIV who may or may not be experiencing problems with their cognition (thinking skills) and are concerned they may have HIV residing in the brain. For further information please click here.

Dysplasia and Anal Cancer Services (DACS)

Associate Professor Richard Hillman
 

DACS provides tests and management for people living with anal cancer and related conditions. It is staffed by dedicated clinicians with extensive experience in the complex procedures required to investigate these matters.

In collaboration with the Kirby Institute at UNSW, we are involved in cutting edge clinical trials and are able to offer state-of-the-art investigations. It is the only centre in eastern Australia to be able to do this, and we have published widely. Our services include:

Referrals to DACS should be considered for those at high risk of anal cancer. This includes:

Those with an established diagnosis of high grade anal intraepithelial neoplasia (AIN2 or AIN3). This is sometimes also known as anal high grade squamous intraepithelial lesions (HSIL). Unexplained anal bleeding or masses in the immunocompromised (especially those with HIV), homosexual men and women with a history of cervical HPV-related disease.

Immunology

Professor Andrew Carr (Director)
Professor Sam Breit
Professor David Cooper
Professor Anthony Kelleher
Dr Winnie Tong (allergy clinic)
 

Services include diagnosis and management of clinical disorders of the immune system, including HIV, allergic diseases, autoimmune diseases, immunodeficiency, immunosuppression and neuroimmunology

The Allergy Clinic provides specialist assessment of the following conditions

  • Anaphylaxis
  • Drug allergy and adverse drug reactions
  • Angioedema and urticaria (after GP assessment and management)
  • Rhinitis/conjunctivitis (after GP assessment and management)
  • Eczema (on referral from a dermatologist)
  • Eosinophilic oesophagitis
  • Asthma that requires clinical immunologist and allergist input
  • Other conditions requiring clinical immunologist and allergist assessment

Please note: this clinic does not provide assessment of food intolerance.

If you anticipate having skin prick testing, please do not take any anti-histamines for 72 hours before your appointment.

Infectious Diseases

Dr David Andresen
Associate Professor Debbie Marriott
Associate Professor Gail Matthews
 

Outpatient consultation and follow-up services are provided by three consultants and a registrar. Ambulatory intravenous antibiotic therapy is supervised though several services including IBAC (Monday-Fridays), Hospital-in-the Clinic (7 days), and Hospital-in-the-Home (7 days).

Viral Hepatitis

Associate Professor Mark Danta
Professor Greg Dore
Associate Professor Gail Matthews
Dianne How Chow (Clinical Nurse Consultant)
Robert Cherry (Registered Nurse)
 

The service provides tests and treatment for people living with Hepatitis C and Hepatitis B.The Viral Hepatitis Clinic is staffed by two full-time nurses and three doctors. We are involved in clinical trials and are excited to be able to offer new, easy-to-tolerate cures for Hepatitis C which have now become available.Additional services include

  • Fibroscans (a test to measure liver scarring)
  • Specialised blood tests
  • Vaccinations for Hepatitis A and B
  • Medical reviews
  • Nutritional advice
  • Social work
  • Support, counselling and advice on how to keep you and people close to you safe and healthy

Referrals

All referrals to IBAC Clinics should contain:

Patient name, address, phone and Medicare number
Doctor to whom you would like them referred
Specialty of that doctor
Reason for Referral
Interpreter required? If yes, language spoken.
Any other necessary information, eg pathology results
 

Please fax referrals to: 02 8382 2090 or email: SVHS.IBACReception@svha.org.au

Referrals will be assessed and triaged, and then you will be contacted by phone to schedule an appointment.

Contact us:

IBAC Reception - Tel: 02 8382 3707

Director
Professor Andrew Carr
Contact secretary - Sharon Mitchell 8382-3359
 

Nursing Unit Manager
Gaynor Beardsworth
Email: gaynor.beardsworth@svha.org.au

Clinical Research

The St Vincent’s Centre for Applied Medical Research (amr.org.au the) conducts clinical research through the Immunology and Infectious Diseases unit (IBAC) . The research includes multi-national clinical trials sponsored by the pharmaceutical industry, as well as St Vincent’s Hospital sponsored academic research studies.

We are closely affiliated with the University of New South Wales, and are a clinical site for many UNSW-sponsored studies.
The studies conducted within AMR-CRP include randomised clinical trials, cohort studies, and sometimes cross-sectional studies. Currently, we have research being conducted across the following therapeutic areas:

• Hepatitis C

• HIV

• HIV post-exposure prophylaxis (PEP) and pre-exposure porphylaxis (PrEP)

• Immunology (e.g. scleroderma)

• Alzheimer’s disease

• Infectious diseases

Contact:
Operations Manager, Clinical Research Program
Trish Chronopolous
Mob:04272444521
Email : trish.chronopoulos@svha.org.au